Skip to main content
Top
Published in: Diabetologia 7/2009

01-07-2009 | Article

Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individuals

Authors: S. C. Lim, J. J. Liu, H. Q. Low, N. G. Morgenthaler, Y. Li, L. Y. Yeoh, Y. S. Wu, S. K. Goh, C. Y. Chionh, S. H. Tan, Y. C. Kon, P. C. Soon, Y. M. Bee, T. Subramaniam, C. F. Sum, K. S. Chia

Published in: Diabetologia | Issue 7/2009

Login to get access

Abstract

Aims/hypothesis

Evolving research suggests that common and rare alleles jointly constitute the genetic landscape of complex disease. We studied the association between 43 pathway-related candidate genes with ‘intermediate phenotype’ (i.e. corresponding plasma protein) and diabetic nephropathy in a customised microarray of 1,536 SNPs.

Methods

In this case–control study of type 2 diabetic Chinese individuals with and without diabetic nephropathy, cases (n = 545) were defined on the basis of a spot urinary albumin/creatinine ratio (ACR) > 113 mg/mmol; the value for controls (n = 503) was ACR < 3.3 mg/mmol. Genotyping was performed using Illumina GoldenGate assay.

Results

No single nucleotide polymorphism (SNP) remained significant in single locus analysis after correction for multiple testing. Therefore, we explored the best ∼1% SNPs. Of these 13 SNPs, four clustered to a 5′ end NADPH oxidase homologue 4 (NOX4) haplotype (GGCC frequency = 0.776) with estimated OR for diabetic nephropathy of 2.05 (95% CI 1.04–4.06) (heterozygous) and 2.48 (1.27–4.83) (homozygous) (p = 0.0055). The haplotype was correlated with plasma Cu/Zn superoxide dismutase (SOD) concentration, suggesting increased oxidative burden. Endothelin-1 SNP (rs1476046G>A, frequency = 0.252) was correlated with plasma C-terminal pro-endothelin-1 concentrations with an estimated OR for diabetic nephropathy of (heterozygous) 1.26 (0.96–1.66) and (homozygous) 1.87 (1.13–3.12) (p = 0.0072). Nitric oxide synthase 1 (NOS1) 5′ haplotype (TGTC frequency = 0.38) also revealed a suggestive association with diabetic nephropathy: heterozygous 1.26 (0.95–1.67), homozygous 1.57 (1.04–2.35) (p = 0.0073). A rare NADPH oxidase homologue 1 (NOX1)-coding non-synonymous SNP (Arg315His, frequency = 0.006) was found exclusively among cases.

Conclusions/interpretation

Our preliminary observations suggest that common haplotypes from NOX4 and endothelin-1 SNP correlated with plasma Cu/Zn SOD and C-terminal pro-endothelin-1 concentrations, respectively, and might have conferred diabetic nephropathy susceptibility. Common NOS1 and rare NOX1 variants also revealed a suggestive association with diabetic nephropathy. Future studies to validate our observation are needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schrijvers BF, de Vriese AS, Flyvbjerg A (2004) From hyperglycaemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 25:971–1010PubMedCrossRef Schrijvers BF, de Vriese AS, Flyvbjerg A (2004) From hyperglycaemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 25:971–1010PubMedCrossRef
2.
go back to reference Liu Y, Freedman BI (2005) Genetics of progressive renal failure in diabetic kidney disease. Kidney Int Suppl 99:S94–S97PubMedCrossRef Liu Y, Freedman BI (2005) Genetics of progressive renal failure in diabetic kidney disease. Kidney Int Suppl 99:S94–S97PubMedCrossRef
4.
go back to reference Colhoun HM, McKeigue PM, Davey Smith G (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361:865–872PubMedCrossRef Colhoun HM, McKeigue PM, Davey Smith G (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361:865–872PubMedCrossRef
5.
go back to reference Ewens KG, George RA, Sharma K, Ziyadeh FN, Spielman RS (2005) Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test. Diabetes 54:3305–3318PubMedCrossRef Ewens KG, George RA, Sharma K, Ziyadeh FN, Spielman RS (2005) Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test. Diabetes 54:3305–3318PubMedCrossRef
6.
go back to reference Shimazaki A, Kawamura Y, Kanazawa A et al (2005) Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 54:1171–1178PubMedCrossRef Shimazaki A, Kawamura Y, Kanazawa A et al (2005) Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 54:1171–1178PubMedCrossRef
7.
go back to reference Hanson RL, Craig DW, Millis MP et al (2007) Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 56:975–983PubMedCrossRef Hanson RL, Craig DW, Millis MP et al (2007) Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 56:975–983PubMedCrossRef
8.
go back to reference Millis MP, Bowen D, Kingsley C, Watanabe RM, Wolford JK (2007) Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes. Diabetes 56:3027–3032PubMedCrossRef Millis MP, Bowen D, Kingsley C, Watanabe RM, Wolford JK (2007) Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes. Diabetes 56:3027–3032PubMedCrossRef
9.
go back to reference International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299–1320CrossRef International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299–1320CrossRef
10.
go back to reference Bodmer W, Bonilla C (2008) Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40:695–701PubMedCrossRef Bodmer W, Bonilla C (2008) Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40:695–701PubMedCrossRef
11.
go back to reference Bhangale TR, Rieder MJ, Nickerson DA (2008) Estimating coverage and power for genetic association studies using near-complete variation data. Nat Genet 40:841–843PubMedCrossRef Bhangale TR, Rieder MJ, Nickerson DA (2008) Estimating coverage and power for genetic association studies using near-complete variation data. Nat Genet 40:841–843PubMedCrossRef
12.
go back to reference American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29:S43–S48 American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29:S43–S48
13.
go back to reference Lim SC, Goh SK, Lai YR et al (2006) Relationship between common functional polymorphisms of the p22phox gene (−930A > G and +242C > T) and nephropathy as a result of type 2 diabetes in a Chinese population. Diabet Med 23:1037–1041PubMedCrossRef Lim SC, Goh SK, Lai YR et al (2006) Relationship between common functional polymorphisms of the p22phox gene (−930A > G and +242C > T) and nephropathy as a result of type 2 diabetes in a Chinese population. Diabet Med 23:1037–1041PubMedCrossRef
14.
go back to reference Bettencourt P, Januzzi JL Jr (2008) Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure. Am J Cardiol 101:67–71PubMedCrossRef Bettencourt P, Januzzi JL Jr (2008) Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure. Am J Cardiol 101:67–71PubMedCrossRef
15.
go back to reference Papassotiriou J, Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clin Chem 52:1144–1151PubMedCrossRef Papassotiriou J, Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clin Chem 52:1144–1151PubMedCrossRef
16.
go back to reference Zelko IN, Mariani TJ, Folz RJ (2002) Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33:337–349PubMedCrossRef Zelko IN, Mariani TJ, Folz RJ (2002) Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33:337–349PubMedCrossRef
17.
go back to reference Clayton DG, Walker NM, Smyth DJ et al (2005) Population structure, differential bias and genomic control in a large-scale, case–control association study. Nat Genet 37:1243–1246PubMedCrossRef Clayton DG, Walker NM, Smyth DJ et al (2005) Population structure, differential bias and genomic control in a large-scale, case–control association study. Nat Genet 37:1243–1246PubMedCrossRef
18.
go back to reference Li Y, Sung WK, Liu JJ (2007) Association mapping via regularized regression analysis of single-nucleotide-polymorphism haplotypes in variable-sized sliding windows. Am J Hum Genet 80:705–715PubMedCrossRef Li Y, Sung WK, Liu JJ (2007) Association mapping via regularized regression analysis of single-nucleotide-polymorphism haplotypes in variable-sized sliding windows. Am J Hum Genet 80:705–715PubMedCrossRef
19.
go back to reference Pawlak K, Pawlak D, Mysliwiec M (2005) Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Clin Biochem 38:700–705PubMedCrossRef Pawlak K, Pawlak D, Mysliwiec M (2005) Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Clin Biochem 38:700–705PubMedCrossRef
20.
go back to reference Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894–3900PubMedCrossRef Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894–3900PubMedCrossRef
21.
go back to reference Li JM, Shah AM (2003) ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 14:S221–S226PubMedCrossRef Li JM, Shah AM (2003) ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 14:S221–S226PubMedCrossRef
22.
go back to reference Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245–313PubMedCrossRef Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245–313PubMedCrossRef
23.
go back to reference Orient A, Donkó A, Szabó A, Leto TL, Geiszt M (2007) Novel sources of reactive oxygen species in the human body. Nephrol Dial Transplant 22:1281–1288PubMedCrossRef Orient A, Donkó A, Szabó A, Leto TL, Geiszt M (2007) Novel sources of reactive oxygen species in the human body. Nephrol Dial Transplant 22:1281–1288PubMedCrossRef
24.
go back to reference Ding H, Hashem M, Triggle C (2007) Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS. Eur J Pharmacol 561:121–128PubMedCrossRef Ding H, Hashem M, Triggle C (2007) Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS. Eur J Pharmacol 561:121–128PubMedCrossRef
25.
go back to reference Richter CM (2006) Role of endothelin in chronic renal failure—developments in renal involvement. Rheumatology 45:iii36–iii38PubMedCrossRef Richter CM (2006) Role of endothelin in chronic renal failure—developments in renal involvement. Rheumatology 45:iii36–iii38PubMedCrossRef
26.
go back to reference Naicker S, Bhoola KD (2001) Endothelins: vasoactive modulators of renal function in health and disease. Pharmacol Ther 90:61–88PubMedCrossRef Naicker S, Bhoola KD (2001) Endothelins: vasoactive modulators of renal function in health and disease. Pharmacol Ther 90:61–88PubMedCrossRef
27.
go back to reference Hargrove GM, Dufresne J, Whiteside C, Muruve DA, Wong NC (2000) Diabetes mellitus increases endothelin-1 gene transcription in rat kidney. Kidney Int 58:1534–1545PubMedCrossRef Hargrove GM, Dufresne J, Whiteside C, Muruve DA, Wong NC (2000) Diabetes mellitus increases endothelin-1 gene transcription in rat kidney. Kidney Int 58:1534–1545PubMedCrossRef
28.
go back to reference Lillie EO, Mahata M, Khandrika S et al (2007) Heredity of endothelin secretion: human twin studies reveal the influence of polymorphism at the chromogranin A locus, a novel determinant of endothelial function. Circulation 115:2282–2291PubMedCrossRef Lillie EO, Mahata M, Khandrika S et al (2007) Heredity of endothelin secretion: human twin studies reveal the influence of polymorphism at the chromogranin A locus, a novel determinant of endothelial function. Circulation 115:2282–2291PubMedCrossRef
29.
go back to reference Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden DW (2000) Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol Dial Transplant 15:1794–1800PubMedCrossRef Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden DW (2000) Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol Dial Transplant 15:1794–1800PubMedCrossRef
30.
go back to reference Kanková K, Stejskalová A, Pácal L et al (2007) Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach. Diabetologia 50:990–999PubMedCrossRef Kanková K, Stejskalová A, Pácal L et al (2007) Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach. Diabetologia 50:990–999PubMedCrossRef
31.
go back to reference Pinto-Sietsma SJ, Herrmann SM, Schmidt-Petersen K et al (2003) Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population. J Am Soc Nephrol 14:2596–2602PubMedCrossRef Pinto-Sietsma SJ, Herrmann SM, Schmidt-Petersen K et al (2003) Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population. J Am Soc Nephrol 14:2596–2602PubMedCrossRef
32.
go back to reference Rossi GP, Pitter G (2006) Genetic variation in the endothelin system: do polymorphisms affect the therapeutic strategies? Ann N Y Acad Sci 1069:34–50PubMedCrossRef Rossi GP, Pitter G (2006) Genetic variation in the endothelin system: do polymorphisms affect the therapeutic strategies? Ann N Y Acad Sci 1069:34–50PubMedCrossRef
33.
go back to reference Diefenbach K, Arjomand-Nahad F, Meisel C et al (2006) Systematic analysis of sequence variability of the endothelin-1 gene: a prerequisite for association studies. Genet Test 10:163–168PubMedCrossRef Diefenbach K, Arjomand-Nahad F, Meisel C et al (2006) Systematic analysis of sequence variability of the endothelin-1 gene: a prerequisite for association studies. Genet Test 10:163–168PubMedCrossRef
34.
go back to reference Stevens PA, Brown MJ (1995) Genetic variability of the ET-1 and the ETA receptor genes in essential hypertension. J Cardiovasc Pharmacol 26(Suppl 3):S9–S12PubMed Stevens PA, Brown MJ (1995) Genetic variability of the ET-1 and the ETA receptor genes in essential hypertension. J Cardiovasc Pharmacol 26(Suppl 3):S9–S12PubMed
35.
go back to reference Winker R, Garland EM, Rüdiger HW et al (2005) Influence of an insertion variant in the 5′UTR of the endothelin-1 gene on orthostatic intolerance. Am J Med Sci 330:166–171PubMedCrossRef Winker R, Garland EM, Rüdiger HW et al (2005) Influence of an insertion variant in the 5′UTR of the endothelin-1 gene on orthostatic intolerance. Am J Med Sci 330:166–171PubMedCrossRef
36.
go back to reference Popowski K, Sperker B, Kroemer HK et al (2003) Functional significance of a hereditary adenine insertion variant in the 5′-UTR of the endothelin-1 gene. Pharmacogenetics 13:445–451PubMedCrossRef Popowski K, Sperker B, Kroemer HK et al (2003) Functional significance of a hereditary adenine insertion variant in the 5′-UTR of the endothelin-1 gene. Pharmacogenetics 13:445–451PubMedCrossRef
37.
go back to reference Komers R, Lindsley JN, Oyama TT, Allison KM, Anderson S (2000) Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes. Am J Physiol Renal Physiol 279:F573–F583PubMed Komers R, Lindsley JN, Oyama TT, Allison KM, Anderson S (2000) Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes. Am J Physiol Renal Physiol 279:F573–F583PubMed
38.
go back to reference Thomson SC, Deng A, Komine N, Hammes JS, Blantz RC, Gabbai FB (2004) Early diabetes as a model for testing the regulation of juxtaglomerular NOS I. Am J Physiol Renal Physiol 287:F732–F738PubMedCrossRef Thomson SC, Deng A, Komine N, Hammes JS, Blantz RC, Gabbai FB (2004) Early diabetes as a model for testing the regulation of juxtaglomerular NOS I. Am J Physiol Renal Physiol 287:F732–F738PubMedCrossRef
39.
go back to reference O'Bryan GT, Hostetter TH (1997) The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol 17:93–100PubMed O'Bryan GT, Hostetter TH (1997) The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol 17:93–100PubMed
40.
go back to reference Hall AV, Antoniou H, Wang Y et al (1994) Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem 269:33082–33090PubMed Hall AV, Antoniou H, Wang Y et al (1994) Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem 269:33082–33090PubMed
41.
go back to reference Komers R, Anderson S (2003) Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 284:F1121–F1137PubMed Komers R, Anderson S (2003) Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 284:F1121–F1137PubMed
42.
go back to reference Iyengar SK, Elston RC (2007) The genetic basis of complex traits: rare variants or “common gene, common disease”? Methods Mol Biol 376:71–84PubMedCrossRef Iyengar SK, Elston RC (2007) The genetic basis of complex traits: rare variants or “common gene, common disease”? Methods Mol Biol 376:71–84PubMedCrossRef
43.
go back to reference Chen G, Adeyemo AA, Zhou J et al (2007) A genome-wide search for linkage to renal function phenotypes in West Africans with type 2 diabetes. Am J Kidney Dis 49:394–400PubMedCrossRef Chen G, Adeyemo AA, Zhou J et al (2007) A genome-wide search for linkage to renal function phenotypes in West Africans with type 2 diabetes. Am J Kidney Dis 49:394–400PubMedCrossRef
44.
go back to reference Davey Smith G, Ebrahim S (2004) Mendelian randomisation: prospects, pitfalls and limitations. Int J Epidemiol 33:30–42CrossRef Davey Smith G, Ebrahim S (2004) Mendelian randomisation: prospects, pitfalls and limitations. Int J Epidemiol 33:30–42CrossRef
45.
go back to reference Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177–182PubMedCrossRef Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177–182PubMedCrossRef
46.
go back to reference Frayling TM, McCarthy MI (2007) Genetic studies of diabetes following the advent of the genome-wide association study: where do we go from here? Diabetologia 50:2229–2233PubMedCrossRef Frayling TM, McCarthy MI (2007) Genetic studies of diabetes following the advent of the genome-wide association study: where do we go from here? Diabetologia 50:2229–2233PubMedCrossRef
47.
go back to reference Stranger BE, Forrest MS, Dunning M et al (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315:848–853PubMedCrossRef Stranger BE, Forrest MS, Dunning M et al (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315:848–853PubMedCrossRef
48.
go back to reference McCarthy MI, Abecasis GR, Cardon LR et al (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9:356–369PubMedCrossRef McCarthy MI, Abecasis GR, Cardon LR et al (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9:356–369PubMedCrossRef
Metadata
Title
Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individuals
Authors
S. C. Lim
J. J. Liu
H. Q. Low
N. G. Morgenthaler
Y. Li
L. Y. Yeoh
Y. S. Wu
S. K. Goh
C. Y. Chionh
S. H. Tan
Y. C. Kon
P. C. Soon
Y. M. Bee
T. Subramaniam
C. F. Sum
K. S. Chia
Publication date
01-07-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1368-x

Other articles of this Issue 7/2009

Diabetologia 7/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.